These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 31756981)

  • 1. Nanoparticle Delivery Systems in the Treatment of Diabetes Complications.
    Souto EB; Souto SB; Campos JR; Severino P; Pashirova TN; Zakharova LY; Silva AM; Durazzo A; Lucarini M; Izzo AA; Santini A
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31756981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent developments in nanoparticles for the treatment of diabetes.
    Sharma DK; Pattnaik G; Behera A
    J Drug Target; 2023 Dec; 31(9):908-919. PubMed ID: 37725445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel strategies to oral delivery of insulin: Current progress of nanocarriers for diabetes management.
    Abdel-Moneim A; Ramadan H
    Drug Dev Res; 2022 Apr; 83(2):301-316. PubMed ID: 34859477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymer-based nanoparticles for oral insulin delivery: Revisited approaches.
    Fonte P; Araújo F; Silva C; Pereira C; Reis S; Santos HA; Sarmento B
    Biotechnol Adv; 2015 Nov; 33(6 Pt 3):1342-54. PubMed ID: 25728065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microparticles, microcapsules and microspheres: A review of recent developments and prospects for oral delivery of insulin.
    Wong CY; Al-Salami H; Dass CR
    Int J Pharm; 2018 Feb; 537(1-2):223-244. PubMed ID: 29288095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for the delivery of antidiabetic drugs via intranasal route.
    Dholakia J; Prabhakar B; Shende P
    Int J Pharm; 2021 Oct; 608():121068. PubMed ID: 34481011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticles prepared from pterostilbene reduce blood glucose and improve diabetes complications.
    Zhao X; Shi A; Ma Q; Yan X; Bian L; Zhang P; Wu J
    J Nanobiotechnology; 2021 Jun; 19(1):191. PubMed ID: 34176494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies to Improve Insulin Delivery through Oral Route: A Review.
    Bhattacharya R; Johnson AP; Shailesh T; Rahamathulla M; H V G
    Curr Drug Deliv; 2022; 19(3):317-336. PubMed ID: 34288838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Trend of Organic Based Nanoparticles in the Treatment of Diabetes and Its Perspectives.
    Natesan V; Kim SJ
    Biomol Ther (Seoul); 2023 Jan; 31(1):16-26. PubMed ID: 36122910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanotechnology in Insulin Delivery for Management of Diabetes.
    Bahman F; Greish K; Taurin S
    Pharm Nanotechnol; 2019; 7(2):113-128. PubMed ID: 30907328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances of polysaccharide-based nanoparticles for oral insulin delivery.
    Hu Q; Luo Y
    Int J Biol Macromol; 2018 Dec; 120(Pt A):775-782. PubMed ID: 30170057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug Delivery Systems for Diabetes Treatment.
    Zaric BL; Obradovic M; Sudar-Milovanovic E; Nedeljkovic J; Lazic V; Isenovic ER
    Curr Pharm Des; 2019; 25(2):166-173. PubMed ID: 30848184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of biodegradable polymeric systems for oral insulin delivery.
    Luo YY; Xiong XY; Tian Y; Li ZL; Gong YC; Li YP
    Drug Deliv; 2016 Jul; 23(6):1882-91. PubMed ID: 26066036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential of insulin nanoparticle formulations for oral delivery and diabetes treatment.
    Wong CY; Al-Salami H; Dass CR
    J Control Release; 2017 Oct; 264():247-275. PubMed ID: 28887133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transition from passive to active targeting of oral insulin nanomedicines: enhancement in bioavailability and glycemic control in diabetes.
    Kaklotar D; Agrawal P; Abdulla A; Singh RP; Mehata AK; Singh S; Mishra B; Pandey BL; Trigunayat A; Muthu MS
    Nanomedicine (Lond); 2016 Jun; 11(11):1465-86. PubMed ID: 27171572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid Nanoparticles for Nasal/Intranasal Drug Delivery.
    Cunha S; Amaral MH; Lobo JMS; Silva AC
    Crit Rev Ther Drug Carrier Syst; 2017; 34(3):257-282. PubMed ID: 28845761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel strategies in the oral delivery of antidiabetic peptide drugs - Insulin, GLP 1 and its analogs.
    Ismail R; Csóka I
    Eur J Pharm Biopharm; 2017 Jun; 115():257-267. PubMed ID: 28336368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Natural and Synthetic Polymers in Formulating Micro and Nanoparticles for Anti-Diabetic Drugs.
    Al-Hashimi N; Babenko M; Saaed M; Kargar N; ElShaer A
    Curr Drug Deliv; 2021; 18(3):271-288. PubMed ID: 32778027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanomedicine for treatment of diabetes in an aging population: state-of-the-art and future developments.
    Krol S; Ellis-Behnke R; Marchetti P
    Maturitas; 2012 Sep; 73(1):61-7. PubMed ID: 22209199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Materials and structure of polysaccharide-based delivery carriers for oral insulin: A review.
    Wang X; Sun H; Mu T
    Carbohydr Polym; 2024 Jan; 323():121364. PubMed ID: 37940264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.